SSI Diagnostica Group has two complementary portfolios with both Life Science and In Vitro Diagnostics. The company serves three main application areas: vaccine development, disease surveillance, and ...
A fter years of work, scientists have solved the mystery of an unusual side effect that impacted some recipients of the Oxford/AstraZeneca and Johnson & Johnson COVID-19 vaccines. Most importantly, ...
Zacks Investment Research on MSN
Near-perfect CPI report brings pre-markets near breakeven
Friday, February 13th, 2026 As far as economic reports go, the good news just keeps on coming. Seemingly running on a separate track from investor fears about AI’s future role in the economy, today’s ...
Mani Foroohar, M.D., of Leerink Partners, says that the decision reflects “how sharp the departure has been between the prior ...
Zacks Investment Research on MSN
Moderna (MRNA) reports Q4 loss, beats revenue estimates
Moderna (MRNA) came out with a quarterly loss of $2.11 per share versus the Zacks Consensus Estimate of a loss of $2.6. This compares to a loss of $2.5 per share a year ago. These figures are adjusted ...
Vinay Prasad, the Trump administration’s top vaccine regulator at the Food and Drug Administration, single-handedly decided ...
Tolemy Bio and GeminiBio in West Sacramento have launched what is recognised as the first AI-enabled media optimisation service for Cell Therapy Manufacturing.
QuitGPT is one of the latest salvos in a growing movement by activists and disaffected users to cancel their subscriptions. In just the past few weeks, users have flooded Reddit with stories about ...
According to Moderna, which used a valuable priority review voucher to speed up the FDA's review, the agency has said that ...
Moderna Inc. (NASDAQ: MRNA) shares declined sharply in after-hours trading on Tuesday after the biotechnology company ...
The vaccine maker’s shots involve the successful Covid vaccines’ RNA technology. Health Secretary Robert F. Kennedy Jr. has ...
From vaccines and diagnostics to emerging gene-based therapies, RNA molecules are now central to modern medicine. But as their use continues to grow, so does a fundamental challenge: producing RNA ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results